New research led by the University of Minnesota Medical School demonstrates that molecules acting as "molecular bumpers" and "molecular glues" can rewire G protein-coupled receptor (GPCR) signaling, ...

Some guys are getting this promising new weight loss drug on the grey market. Here's what it does and the risks of taking it ...

GLP-1 receptor agonists may have beneficial effects against Alzheimers, psychiatric and addiction disorders, but early data ...

"We've greatly misjudged and mis-prioritized the mental health of mothers in general and we've gotten a lot of it wrong." ...

The endocannabinoid system is one of the most diffuse neurotransmitter systems in the body and the brain. Understanding its ...

Elinzanetant belongs to a new class of drugs designed to target what is believed to be a key mechanism responsible for ...

Cancer immunotherapy, especially using T cells, is showing a lot of promise in treating blood cancers. Bioengineered T cells, ...

Sean Virani, MD, lead author of the new guidelines and president of the CCS, explained that the guidelines use the term ...

If approved, it would be the first major new drug treatment for Parkinson’s in half a century. Richard Mailman, a University ...

This article was reviewed by Darragh O’Carroll, MD. Ozempic Alternatives for Weight Loss Key takeaways: Ozempic® alternatives ...

Cancer immunotherapy, especially using T cells, is showing a lot of promise in treating blood cancers. Bioengineered T cells, ...

As a scientist and a parent of a child with autism, Srinivas Sridhar has a proposal for leucovorin for autism.